BIONTECH
Summary
BioNTech is a clinical-stage biotechnology company focused on patient-specific immunotherapies for the treatment of cancer and other serious diseases.
Deals Overview
Total Dealss11
Valued Deals8
Total Value£ 2.96 B
Avg. Deal Size£ 370 M
All rights reserved. Copyright © 2025 Datasite
